Paolo Serra

1.3k total citations
20 papers, 486 citations indexed

About

Paolo Serra is a scholar working on Pulmonary and Respiratory Medicine, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Paolo Serra has authored 20 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Paolo Serra's work include Cardiac pacing and defibrillation studies (4 papers), Cardiac Arrhythmias and Treatments (4 papers) and Advanced Breast Cancer Therapies (3 papers). Paolo Serra is often cited by papers focused on Cardiac pacing and defibrillation studies (4 papers), Cardiac Arrhythmias and Treatments (4 papers) and Advanced Breast Cancer Therapies (3 papers). Paolo Serra collaborates with scholars based in Italy, United States and Spain. Paolo Serra's co-authors include Paolo Emilio Manconi, Aldo Quattrone, Rita Cittadella, Carlo Carcassi, Giorgio La Nasa, Licinio Contu, Roberto Littera, Alessandro Masala, Francesco Perna and Paola Piano and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Paolo Serra

17 papers receiving 469 citations

Peers

Countries citing papers authored by Paolo Serra

Since Specialization

Citations

This map shows the geographic impact of Paolo Serra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Serra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Serra more than expected).

Fields of papers citing papers by Paolo Serra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Serra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Serra. The network helps show where Paolo Serra may publish in the future.

Co-authorship network of co-authors of Paolo Serra

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Serra. A scholar is included among the top collaborators of Paolo Serra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Serra. Paolo Serra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A real-life evaluation of SNOT-22 domains in a cohort of CRSwNP patients treated with biologic therapies for 12 months 2025 ·World Allergy Organization Journal ·Giulia Costanzo, Andrea Ledda, (unknown), Giuseppe Murdaca, Cristiano Caruso, (unknown), Paolo Serra, Maria Pina Barca, Stefano Del Giacco, Davide Firinu	0
2	Eosinophil Cationic Protein Variation in Patients with Asthma and CRSwNP Treated with Dupilumab 2023 ·Life ·Andrea Ledda, Giulia Costanzo, (unknown), Cristiano Caruso, (unknown), Maria Luisa Martino, Paolo Serra, Davide Firinu, Stefano Del Giacco	6
3	Justifying Ribociclib Dose in Patients with Advanced Breast Cancer with Renal Impairment Based on PK, Safety, and Efficacy Data: An Innovative Approach Integrating Data from a Dedicated Renal Impairment Study and Oncology Clinical Trials 2023 ·Clinical Pharmacokinetics ·Yan Ji, (unknown), Michelle Quinlan, Paolo Serra, Yingbo Wang, Abhijit Chakraborty, Michelle C. Miller	6
4	Abstract GS2-01: Overall survival subgroup analysis by metastatic site from the phase 3 MONALEESA-2 study of first-line ribociclib + letrozole in postmenopausal patients with advanced HR+/HER2− breast cancer 2022 ·Cancer Research ·Joyce O’Shaughnessy, Salomon M. Stemmer, Howard A. Burris, Yoon Sim Yap, Gabe S. Sonke, Lowell L. Hart, Mario Campone, Katarína Petráková, Eric P. Winer, Wolfgang Janni, Pierfranco Conté, David Cameron, Fabrice André, Carlos L. Arteaga, Juan Pablo Zarate, Arunava Chakravartty, Tetiana Taran, Fabienne Le Gac, Paolo Serra, Gabriel N. Hortobágyi	0
5	EPIK-B5: A phase III, randomized study of alpelisib (ALP) plus fulvestrant (FUL) in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), PIK3CA-mutated advanced breast cancer (ABC) progressing on/after an aromatase inhibitor (AI) with a cyclin-dependent kinase 4/6 inhibitor (CDK4/6i). 2022 ·Journal of Clinical Oncology ·Michelino De Laurentiis, Luís Costa, Joseph Gligorov, (unknown), Elżbieta Senkus, José Á. García-Sáenz, Peter Schmid, (unknown), Paolo Serra, Albert Reising, Sherko Küemmel	7
6	<p>Advanced Medical Devices for Preparation and Administration of Chemotherapeutic Agents: Results from a Multi-Dimensional Evaluation</p> 2020 ·ClinicoEconomics and Outcomes Research ·Lucrezia Ferrario, (unknown), (unknown), (unknown), (unknown), Paolo Serra, Emanuele Porazzi, Emanuela Foglia	0
7	Performance of the Durata implantable cardioverter defibrillator lead: results of an independent multicenter study 2019 ·Journal of Cardiovascular Medicine ·Roberto Rordorf, Erika Taravelli, Giovanni B. Forleo, (unknown), Vittorio Calzolari, Giorgio Tadeo, (unknown), Alfredo Vicentini, Antonio Curnis, Paolo Serra, Matteo Santamaria, Leonardo Calò	3
8	New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial 2015 ·Heart Rhythm ·Luigi Padeletti, Helmut Pürerfellner, Lluı́s Mont, Raymond Tukkie, Antonis S. Manolis, Renato Pietro Ricci, Giuseppe Inama, Paolo Serra, Mike Scheffer, (unknown), Eduardo N. Warman, Marco Vimercati, Andrea Grammatico, Giuseppe Boriani	35
9	Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial 2015 ·Heart Rhythm ·Giuseppe Boriani, Antonis S. Manolis, Raymond Tukkie, Lluı́s Mont, Helmut Pürerfellner, Massimo Santini, Giuseppe Inama, Paolo Serra, Michele Massimo Gulizia, (unknown), Claudia Wolff, Reece Holbrook, (unknown), Luigi Padeletti	8
10	Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial 2014 ·European Heart Journal ·Giuseppe Boriani, Raymond Tukkie, Antonis S. Manolis, Lluı́s Mont, Helmut Pürerfellner, Massimo Santini, Giuseppe Inama, Paolo Serra, João de Sousa, Giovanni Luca Botto, Lorenza Mangoni, Andrea Grammatico, Luigi Padeletti, (unknown)	80
11	Highlights of Italian hospital pharmacy: experiences and research 2012 ·European Journal of Hospital Pharmacy ·(unknown), Valeria Fadda, Paolo Serra, (unknown), Francesco Cattel, (unknown), Francesca Venturini	1
12	Successful Treatment of Chronic Mucocutaneous Candidiasis Caused by Azole-ResistantCandida albicanswith Posaconazole 2010 ·SHILAP Revista de lepidopterología ·Davide Firinu, Orietta Massidda, (unknown), (unknown), (unknown), Maria Pina Barca, Paolo Serra, Paolo Emilio Manconi	10
13	HLA-dependent hypersensitivity to nevirapine in Sardinian HIV patients 2006 ·AIDS ·Roberto Littera, Carlo Carcassi, Alessandro Masala, Paola Piano, Paolo Serra, Francesco Perna, (unknown), (unknown), Giorgio La Nasa, Licinio Contu, Paolo Emilio Manconi	116
14	ApoE Epsilon4 Allele and Disease Duration Affect Verbal Learning in Mild Temporal Lobe Epilepsy 2005 ·Epilepsia ·Antonio Gambardella, Umberto Aguglia, R. Chifari, Angelo Labate, Ida Manna, Paolo Serra, Nelide Romeo, (unknown), (unknown), Antonella La Russa, Patrizia Ventura, Rita Cittadella, Francesco Sasanelli, (unknown), Ugo Leggio, Mario Zappia, Aldo Quattrone	47
15	Association between Synapsin III gene promoter polymorphisms and multiple sclerosis 2004 ·Journal of Neurology ·Maria Liguori, Rita Cittadella, Ida Manna, Paola Valentino, Antonella La Russa, Paolo Serra, María Trojano, Demetrio Messina, (unknown), Virginia Andreoli, Nelide Romeo, Paolo Livrea, Aldo Quattrone	16
16	Increased Risk for Alzheimer Disease With the Interaction of MPO and A2M Polymorphisms 2004 ·Archives of Neurology ·Mario Zappia, Ida Manna, Paolo Serra, Rita Cittadella, Virginia Andreoli, Antonella La Russa, (unknown), Patrizia Spadafora, Nelide Romeo, Giuseppe Nicoletti, Demetrio Messina, Antonio Gambardella, Aldo Quattrone	47
17	Prodynorphin Gene Promoter Polymorphism and Temporal Lobe Epilepsy 2003 ·Epilepsia ·Antonio Gambardella, Ida Manna, Angelo Labate, R. Chifari, Paolo Serra, Antonella La Russa, (unknown), Rita Cittadella, Virginia Andreoli, Francesco Sasanelli, Mario Zappia, Umberto Aguglia, Aldo Quattrone	24
18	Apolipoprotein E genotype does notinfluence the progression of multiple sclerosis 2003 ·Journal of Neurology ·Giovanni Savettieri, Virginia Andreoli, Simona Bonavita, Rita Cittadella, Carlo Caltagirone, Maria Fazio, Paolo Girlanda, Francesco Le Pira, Maria Liguori, Giancarlo Logroscino, Alessandra Lugaresi, Ugo Nocentini, A. Reggio, Giuseppe Salemi, Paolo Serra, Gioacchino Tedeschi, (unknown), María Trojano, Paola Valentino, Aldo Quattrone	34
19	Chemokines and Pro-Inflammatory Cytokines in Down’s Syndrome: An Early Marker for Alzheimer-Type Dementia? 2002 ·Psychotherapy and Psychosomatics ·Mauro Giovanni Carta, Paolo Serra, (unknown), (unknown), Maria Carolina Hardoy, Del Giacco Gs, Giacomo Diaz, Bernardo Carpiniello, Paolo Emilio Manconi	40
20	No evidence of association between the alpha-2 macroglobulin gene and Parkinson's disease in a case–control sample 2002 ·Neuroscience Letters ·Giuseppe Nicoletti, Grazia Annesi, Carmine Tomaino, Patrizia Spadafora, Angela Aurora Pasqua, Ferdinanda Annesi, Paolo Serra, Manuela Caracciolo, Demetrio Messina, Mario Zappia, Aldo Quattrone	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact